Frailty and malnutrition predictive of mortality risk in older patients with advanced colorectal cancer receiving chemotherapy

Journal of Geriatric Oncology

Volumn 4, Issue 3, 2013, Pages 218-226

  Aaldriks, Ab A ^a   van der Geest, Lydia G M ^b   Giltay, Erik J ^c   le Cessie, Saskia ^c   Portielje, Johanneke E A ^d   Tanis, Bea C ^e   Nortier, Johan W R ^c   Maartense, Ed ^f  

^a Bouman Geestelijke Gezondheidszorg   (Netherlands)

^b Department of Cancer Registry and Research   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d HAGA HOSPITAL   (Netherlands)

^e GROENE HART HOSPITAL   (Netherlands)

^f REINIER DE GRAAF HOSPITAL   (Netherlands)

Author keywords

Chemotherapy; Colorectal cancer; Elderly; Geriatric assessment

Indexed keywords

BEVACIZUMAB; CAPECITABINE; FLUOROURACIL; FOLINIC ACID; OXALIPLATIN;

ADD ON THERAPY; ADVANCED CANCER; AGED; ARTICLE; BLOOD TOXICITY; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER PALLIATIVE THERAPY; CLINICAL ASSESSMENT; COLORECTAL CANCER; DIARRHEA; DISEASE ASSOCIATION; DRUG TOLERABILITY; FATIGUE; FEASIBILITY STUDY; FEMALE; FRAIL ELDERLY; GRONINGEN FRAILTY INDICATOR; HUMAN; INFORMANT QUESTIONNAIRE ON COGNITIVE DECLINE IN THE ELDERLY; MAJOR CLINICAL STUDY; MALE; MALNUTRITION; MINI MENTAL STATE EXAMINATION; MINI NUTRITIONAL ASSESSMENT; MULTIPLE CYCLE TREATMENT; NUTRITIONAL ASSESSMENT; OUTCOME ASSESSMENT; POLYNEUROPATHY; PREDICTIVE VALUE; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; SCORING SYSTEM;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CHEMOTHERAPY, ADJUVANT; COGNITION DISORDERS; COLONIC NEOPLASMS; FEMALE; FRAIL ELDERLY; HUMANS; MALE; MALNUTRITION; NUTRITION ASSESSMENT; PALLIATIVE CARE; PROSPECTIVE STUDIES; RECTAL NEOPLASMS; RISK FACTORS;

EID: 84878956865     PISSN: 18794068     EISSN: 18794076     Source Type: Journal    
DOI: 10.1016/j.jgo.2013.04.001     Document Type: Article

References (39)

1. Integraal Kankercentrum Nederland http://www.cijfersoverkanker.nl.
2. Siegel R., Naishadham D., Jemal A. Cancer statistics, 2012. CA Cancer J Clin Jan-Feb 2012, 62(1):10-29.
3. Brenner H., Bouvier A.M., Foschi R., Hackl M., Larsen I.K., Lemmens V., et al. Progress in colorectal cancer survival in Europe from the late 1980s to the early 21st century: The EUROCARE study. Int J Cancer 2011, 23(May):1-10.
4. Elferink M.A., van Steenbergen L.N., Krijnen P., Lemmens V.E., Rutten H.J., Marijnen C.A., et al. Marked improvements in survival of patients with rectal cancer in the Netherlands following changes in therapy, 1989-2006. Eur J Cancer 2010, 46(8):1421-1429.
5. van Steenbergen L.N., Elferink M.A., Krijnen P., Lemmens V.E., Siesling S., Rutten H.J., et al. Improved survival of colon cancer due to improved treatment and detection: a nationwide population-based study in The Netherlands 1989-2006. Ann Oncol 2010, 21(11):2206-2212.
6. Balducci L., Colloca G., Cesari M., Gambassi G. Assessment and treatment of elderly patients with cancer. Surg Oncol 2010, 19(3):117-123.
7. Extermann M., Aapro M., Bernabei R., Cohen H.J., Droz J.P., Lichtman S., et al. Use of comprehensive geriatric assessment in older cancer patients: recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG). Crit Rev Oncol Hematol 2005, 55(3):241-252.
8. Extermann M., Hurria A. Comprehensive geriatric assessment for older patients with cancer. J Clin Oncol 2007, 25(14):1824-1831.
9. Maas H.A., Janssen-Heijnen M.L., Olde Rikkert M.G., Machteld Wymenga A.N. Comprehensive geriatric assessment and its clinical impact in oncology. Eur J Cancer 2007, 43(15):2161-2169.
10. Papamichael D., Audisio R., Horiot J.C., Glimelius B., Sastre J., Mitry E., et al. Treatment of the elderly colorectal cancer patient: SIOG expert recommendations. Ann Oncol 2009, 20(1):5-16.
11. Aaldriks A.A., Maartense E., le Cessie S., Giltay E.J., Verlaan H.A., van der Geest L.G., et al. Predictive value of geriatric assessment for patients older than 70years, treated with chemotherapy. Crit Rev Oncol Hematol 2011, 79(2):205-212.
12. Comprehensive Cancer Centre the Netherlands (CCCNL) National evidence based guidelines for colon and rectal cancer 2008 [Accessed December 5, 2011]. http://www.oncoline.nl.
13. Guigoz Y., Lauque S., Vellas B.J. Identifying the elderly at risk for malnutrition. The Mini Nutritional Assessment. Clin Geriatr Med 2002, 18(4):737-757.
14. Vellas B., Guigoz Y., Garry P.J., Nourhashemi F., Bennahum D., Lauque S., et al. The Mini Nutritional Assessment (MNA) and its use in grading the nutritional state of elderly patients. Nutrition 1999, 15(2):116-122.
15. Slaets J.P. Vulnerability in the elderly: frailty. Med Clin North Am 2006, 90(4):593-601.
16. Jorm A.F., Jacomb P.A. The Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): socio-demographic correlates, reliability, validity and some norms. Psychol Med 1989, 19(4):1015-1022.
17. de Jonghe J.F. Differentiating between demented and psychiatric patients with the Dutch version of the IQCODE. Int J Geriatr Psychiatry 1997, 12(4):462-465.
18. Folstein M.F., Folstein S.E., McHugh P.R. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975, 12(3):189-198.
19. Charlson M.E., Pompei P., Ales K.L., MacKenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987, 40(5):373-383.
20. Koroukian S.M., Murray P., Madigan E. Comorbidity, disability, and geriatric syndromes in elderly cancer patients receiving home health care. J Clin Oncol 2006, 24(15):2304-2310.
21. Extermann M., Boler I., Reich R.R., Lyman G.H., Brown R.H., Defelice J., et al. Predicting the risk of chemotherapy toxicity in older patients: the chemotherapy risk assessment scale for high-age patients (CRASH) score. Cancer 2012, 118(13):3377-3386.
22. Hurria A., Togawa K., Mohile S.G., Owusu C., Klepin H.D., Gross C.P., et al. Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study. J Clin Oncol 2011, 29(25):3457-3465.
23. Caillet P., Canoui-Poitrine F., Vouriot J., Berle M., Reinald N., Krypciak S., et al. Comprehensive geriatric assessment in the decision-making process in elderly patients with cancer: ELCAPA study. J Clin Oncol 2011, 29(27):3636-3642.
24. Aschele C., Bergamo F., Lonardi S. Chemotherapy for operable and advanced colorectal cancer. Cancer Treat Rev 2009, 35(6):509-516.
25. Jessup J.M., Stewart A., Greene F.L., Minsky B.D. Adjuvant chemotherapy for stage III colon cancer: implications of race/ethnicity, age, and differentiation. JAMA 2005, 294(21):2703-2711.
26. Folprecht G., Seymour M.T., Saltz L., Douillard J.Y., Hecker H., Stephens R.J., et al. Irinotecan/fluorouracil combination in first-line therapy of older and younger patients with metastatic colorectal cancer: combined analysis of 2,691 patients in randomized controlled trials. J Clin Oncol 2008, 26(9):1443-1451.
27. Sargent D.J., Goldberg R.M., Jacobson S.D., Macdonald J.S., Labianca R., Haller D.G., et al. A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients. N Engl J Med 2001, 345(15):1091-1097.
28. Pallis A.G., Papamichael D., Audisio R., Peeters M., Folprecht G., Lacombe D., et al. EORTC Elderly Task Force experts' opinion for the treatment of colon cancer in older patients. Cancer Treat Rev 2010, 36(1):83-90.
29. Whitson H.E., Purser J.L., Cohen H.J. Frailty thy name is ... Phrailty?. J Gerontol A Biol Sci Med Sci Jul 2007, 62(7):728-730.
30. Saif M.W., Lichtman S.M. Chemotherapy options and outcomes in older adult patients with colorectal cancer. Crit Rev Oncol Hematol 2009, 72(2):155-169.
31. Sastre J., Aranda E., Massuti B., Tabernero J., Chaves M., Abad A., et al. Elderly patients with advanced colorectal cancer derive similar benefit without excessive toxicity after first-line chemotherapy with oxaliplatin-based combinations: comparative outcomes from the 03-TTD-01 phase III study. Crit Rev Oncol Hematol 2009, 70(2):134-144.
32. Balducci L., Extermann M. Management of cancer in the older person: a practical approach. Oncologist 2000, 5(3):224-237.
33. Pallis A.G., Wedding U., Lacombe D., Soubeyran P., Wildiers H. Questionnaires and instruments for a multidimensional assessment of the older cancer patient: what clinicians need to know?. Eur J Cancer 2010, 46(6):1019-1025.
34. Soubeyran P., Fonck M., Blanc-Bisson C., Blanc J.F., Ceccaldi J., Mertens C., et al. Predictors of early death risk in older patients treated with first-line chemotherapy for cancer. J Clin Oncol 2012, 30(15):1829-1834.
35. Kanesvaran R., Li H., Koo K.N., Poon D. Analysis of prognostic factors of comprehensive geriatric assessment and development of a clinical scoring system in elderly Asian patients with cancer. J Clin Oncol 2011, 29(27):3620-3627.
36. Hamaker M.E., Jonker J.M., de Rooij S.E., Vos A.G., Smorenburg C.H., van Munster B.C. Frailty screening methods for predicting outcome of a comprehensive geriatric assessment in elderly patients with cancer: a systematic review. Lancet Oncol Oct 2012, 13(10):e437-e444.
37. Hamaker M.E., Vos A.G., Smorenburg C.H., de Rooij S.E., van Munster B.C. The value of geriatric assessments in predicting treatment tolerance and all-cause mortality in older patients with cancer. Oncologist 2012, 17(11):1439-1449.
38. Jansen C.E., Miaskowski C., Dodd M., Dowling G., Kramer J. A metaanalysis of studies of the effects of cancer chemotherapy on various domains of cognitive function. Cancer 2005, 104(10):2222-2233.
39. Repetto L., Fratino L., Audisio R.A., Venturino A., Gianni W., Vercelli M., et al. Comprehensive geriatric assessment adds information to Eastern Cooperative Oncology Group performance status in elderly cancer patients: an Italian Group for Geriatric Oncology Study. J Clin Oncol 2002, 20(2):494-502.